CRIS Current Research Information System

Tiseo M, Bordi P, Bortesi B, Azzoni C, Campanini N, Boni L, et al. (2009). ERCC 1/BRCA1 PROTEIN EXPRESSIONS AND ERCC1/XPD/XRCC1-3 GENE POLYMORPHISMS AS PREDICTOR FACTORS OF OUTCOME IN STAGE IIIB-IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED IN FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CISPLATIN. ANNALS OF ONCOLOGY, 20, 1695-1703.

ERCC 1/BRCA1 PROTEIN EXPRESSIONS AND ERCC1/XPD/XRCC1-3 GENE POLYMORPHISMS AS PREDICTOR FACTORS OF OUTCOME IN STAGE IIIB-IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED IN FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CISPLATIN

ARDIZZONI, ANDREA
2009
2009
Tiseo M, Bordi P, Bortesi B, Azzoni C, Campanini N, Boni L, et al. (2009). ERCC 1/BRCA1 PROTEIN EXPRESSIONS AND ERCC1/XPD/XRCC1-3 GENE POLYMORPHISMS AS PREDICTOR FACTORS OF OUTCOME IN STAGE IIIB-IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED IN FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CISPLATIN. ANNALS OF ONCOLOGY, 20, 1695-1703.
Tiseo M; Bordi P; Bortesi B; Azzoni C; Campanini N; Boni L; Boni C; Baldini E; Grossi F; Recchia F; Zanelli F; Fontanini G; Naldi N; Rindi G; Bordi C;...espandi
1.06 Abstract in rivista
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/595256
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact